Sutro Biopharma (STRO) Times Interest Earned (2017 - 2022)

Sutro Biopharma has reported Times Interest Earned for 9 years, with the latest figure at $5.36 in Q4 2025.

• Quarterly Times Interest Earned rose 102.03% year-over-year to $5.36 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $70.29 (down 49.09% YoY) and the FY2025 annual result came in at -$0.58, up 44.41% from the prior year.
• Times Interest Earned climbed to $5.36 in Q4 2025 per STRO's latest filing, from -$2.46 in the prior quarter.
• Over five years, Times Interest Earned peaked at $5.36 in Q4 2025 and troughed at -$264.2 in Q4 2024.
• A 5-year average of -$37.8 and a median of -$9.48 in 2021 frame the typical range for Times Interest Earned.
• The sharpest annual moves came in 2022 and 2025: Times Interest Earned sank 11254.32% in 2022, then jumped 102.03% in 2025.
• Over 5 years, Times Interest Earned stood at -$9.53 in 2021, then sank by 1109.13% to -$115.27 in 2022, then jumped by 91.82% to -$9.43 in 2023, then plunged by 2700.48% to -$264.2 in 2024, then surged by 102.03% to $5.36 in 2025.
• According to Business Quant data, Times Interest Earned over the past three periods registered $5.36, -$2.46, and -$0.15 for Q4 2025, Q3 2025, and Q2 2025 respectively.